| Page 28 | Cafepharma

You are here

Primary tabs

Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA (perampanel) Pediatric Indications

Post date: April 2, 2018 - 12:31am

In surprise announcement, FDA determines that cafepharma's website is a drug and company must submit an NDA

Post date: March 30, 2018 - 1:43pm

New Study Reveals Potential for DotLab Endometriosis Saliva Test to be Used for Monitoring Disease Progression and Treatment Response

Post date: March 29, 2018 - 11:13pm

CDI Labs' Monoclonal Antibody Development Pipeline Featured in Nature Methods

Post date: March 28, 2018 - 9:57pm

Sometimes FDA Citizen Petitions Can Actually be Funny

Post date: March 28, 2018 - 1:51pm

Patient Voice Search Behavior Survey Revealing New Insights on the Impact of Voice Search on the Healthcare Industry

Post date: March 28, 2018 - 9:31am

Lumenis reports exciting study outcomes for its endometriosis treatment

Post date: March 27, 2018 - 9:44am

Follow-up study finds evidence of delay of knee replacement with Ampion injections

Post date: March 26, 2018 - 9:45am

Novartis' Siponimod significantly improved outcomes in PhIII data published in Lancet

Post date: March 23, 2018 - 12:47am

Healthcare on the Hill - House Passes "Right to Try" on Second Attempt

Post date: March 22, 2018 - 9:15am

Pages